5-[[(4-Fluorophenyl)methyl]amino]-1, 3-dihydro-2H-imidazo[4, 5-b]pyridin-2-one-d4 Catalog No.:M23888-C As of December 2013 the

As of December 2013 the drug is not approved for these indications in North America or Europe

Molecular characterization of the β-amyloid(4-10) epitope of plaque specific Aβ antibodies by affinity-mass spectrometry using alanine site mutation

is a potent CDK12 inhibitor with an IC50 of 0

Molecular Weight: 618

5-[[(4-Fluorophenyl)methyl]amino]-1, 3-dihydro-2H-imidazo[4, 5-b]pyridin-2-one-d4 Catalog No.:M23888-C As of December 2013 theProduct information CAS Number: 1346598 41 1 Molecular Weight: 262. 28 Formula: C13H11FN4O Chemical Name: 5 {[(4 fluorophenyl)methyl]amino}(H) 1H,2H,3H imidazo[4,5 b]pyridin 2 one Smiles: [2H]N1C(=O)N([2H])C2=C1N=C(NCC1C=CC(F)=CC=1)C([2H])=C2[2H] InChiKey: GEBXVBUWZIPSFP NCCCBSRGSA N InChi: InChI=1S C13H11FN4O c14 9 3 1 8(2 4 9)7 15 11 6 5 10 12(17 11)18 13(19)16 10 h1 6H,7H2,(H3,15,16,17,18,19) i5D,6D hD2 Technical Data Appearance: Solid Power